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and intestinal damage in rats with partial intestinal obstruction
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Abstract: Objective: One of the reasons of bacterial translocation (BT) is the complete or partial intestinal ob-
structions (PIO) of the gastrointestinal system. In this study, we aimed to investigate the effects of recombinant 
human Growth Hormone (rhGH) on BT in rats with partial intestinal obstruction (PIO).
Material and methods: The rats were randomly divided into the 4 groups: Group I: Sham-operated (SO) (n = 
12), Group II control PIO (n = 12), Group III: PIO with rhGH treatment for 5 days (n = 12), Group IV: PIO with 
rhGH treatment 5 days before PIO and 5 days after PIO (a total of 10 days) (n = 12). In the groups III and IV, 
the effects of 5 and 10 days administered rhGH were examined. 
Results: The level of serum and of intestinal fl uid IgA was signifi cantly higher in the Group IV compared to the 
Group I, Group II and Group III. In the Group IV, the number of small intestinal goblet and colonic goblet cells, 
and the lengths of intestinal mucosal villi and crypt depths were statistically signifi cantly higher than in Groups 
II and III. The rate of bacterial translocation was higher in the Group II: 100 % in MLNs, 41.6 % in blood culture 
and 50.8 % in the liver cultures, it was signifi cantly higher compared to the other groups (p < 0.01). 
Conclusions: The study results demonstrated that administration of rhGH to the rats with PIO for at least 10 
days decreased bacterial translocation (Fig. 3, Ref. 25). Text in PDF www.elis.sk.
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The gastrointestinal system (GIS) as well as its functions of 
motility, absorption and secretion, has also immunologic, meta-
bolic, endocrine functions and provides a mucosal defense barrier 
against translocation of bacteria/toxins from gut lumen into circula-
tion and extra intestinal tissues (1). Bacterial translocation (BT) is 
defi ned as the passage of viable bacteria from the gastrointestinal 
tract through the epithelial mucosa. Intestinal bacterial overgrowth, 
intestinal hypomotility and increased mucosal permeability, im-
munodefi ciencies are mechanisms suggested to increase BT (2, 3).
Partial intestinal obstructions (PIO) induce intestinal bacte-
rial overgrowth and subsequently promote translocation (4). In 
the complete and PIO, microorganisms remain in close and long-
term contact with the mucosa because of an impaired peristalsis 
and decreased amount of mucus. In these patients, the number of 
endogenous microorganisms increases besides intra-luminal stasis 
and the fl uid accumulation (5, 6). Catabolic events and gastroin-
testinal dysfunction leads to the passage of the bacteria fi rst in 
mesenteric lymph ganglions (MLGs) and then to other tissues and 
organs by increasing the mucosal permeability (12, 2). 
Various trophic factors are tried and found effective in order 
to protect the integrity of GIS mucosa, at the same time, pointed 
that they decreased BT as well (2, 7–10). Although protective ef-
fects of GH have been reported in various studies of impairment 
of the gastrointestinal mucosa, including stress, sepsis, ischemia 
and subsequent reperfusion, the precise mechanisms of GI protec-
tion of GH are still unclear (11–15).
The aim of the present study was to evaluate the effects of 
subcutaneously administered GH on bacterial translocation (BT) 
in rats with partial intestinal obstruction.
Material and method
The study was conducted in the Experimental Laboratory 
at Selcuk University, Medical Faculty. All procedures were per-
formed according to the Guide for the Care and Use of Laboratory 
Animals. All protocols were approved by the Institutional Animal 
Care and Use Committee of the University and followed the in-
stitutional guidelines for the care and use of laboratory animals. 
Experiments were performed on 48 Wistar Albino adult male rats 
weighted 250–300 grams. The animals were housed in wire mesh 
cages, at normal room temperature, and a 12-hour light/dark. The 
animals were fasted for 8 hours before and during experiment, and 
received serum physiologic (SF) of 100 ml/kg/day via subcutane-
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ous route in the morning and evening for replacement. The rats 
were randomly divided into the 4 groups: Group I: Sham-operated 
(SO) (n = 12), Group II control PIO (n = 12), Group III: PIO with 
rhGH treatment for 5 days (n = 12), Group IV: PIO with rhGH 
treatment 5 days before PIO and 5 days after PIO (a total of 10 
days) (n = 12). In the groups III and IV, the effects of 5 and 10 
days administered rhGH were examined. 
Surgical procedures
All procedures were performed under ether anesthesia applied 
30 min prior to the experiment. The middle laparotomy was per-
formed under sterile conditions. PIO was made with placement 
of a 8F nutrition catheter 5 cm proximal of ileocecal valve to the 
anti-mesenteric edge of the bowel and ligation together with the 
bowel, using a 4/0 atraumatic silk. After the removal of the cath-
eter, the passage from the proximal of the stenosis area to the 
distal bowel was controlled. In the Sham group, 5 minutes after 
the formation of partial intestinal obstruction, both catheter and 
silk were removed. 
The rats in the group III received rhGH (16 IU/ml of Genotro-
pin, 3 IU/mg of specifi c activity, 1 ml of Kabi Pharmacia,16 IU of 
Recombinant somatotropin, 2.0 mg of aminoacetic acid, 41 mg 
mannitol, 0.29 mg of sodium dihydrogen phosphate, 0.28 mg of 
disodium phosphate, 3.0 mg of m-cresol, 1 ml. of water for injec-
tion, 1.15 ml of the volume of the solution) between 08.00 AM and 
08.00 PM at a dose of 1.0 mg/kg/day subcutaneously for 5 days, 
immediately after the operation. In the group IV, rhGH started 5 
days before PIO and continued 5 days after ligation at the same 
dose (a total of 10 days). All groups underwent reoperation on the 
5th day after PIO. Blood, intestinal fl uid, hepatic and mesentery 
lymph ganglions samples were obtained for biochemical, immu-
nological, microbiological and histopathological analysis. He-
patic tissue and MLGs were squeezed and cultured. Culture was 
performed on eosin-methylene-blue (EMB), bloody medium and 
Saboroud-dextrose medium. Serum and intestinal fl uid IgA were 
measured using radial immunodiffusion method. 
Histological examination of intestinal mucosa
Small intestinal specimens were taken 5 cm proximal from 
ligation and from ascending colon. Small and large intestinal 
specimens (6 samples per animal) were fi xed in formaldehyde, 
dehydrated with alcohol and embedded in paraffi n, then cut in 
5μm sections and stained with hematoxylin eosin and Periodic 
acid-Schiff reaction (PAS). The specimens were assessed under a 
light microscope by the same experienced pathologist. Length and 
depth calculations of the intestinal villous and crypts were per-
formed with an eyepiece micrometer under the light microscope 
(BH-2 Olympus), micrometer calibration was done for 40 magni-
tude objective. The calculation of Goblet cells were done on PAS 
stained slides by counting the total number of purple stained cells 
which easily can be distinguished from other enterocytes lined on 
villous and crypts. For evaluation of length, depth’s and goblet 
number, measurements were done as repeating every sample for 
six distinct times, then taking the arithmetic mean of this six for 
student’s-T test statistical analysis. To make more open this “six” 
returns; for each animal (n = 12x4 = 48) six slide was prepared 
(total 288 slides) and for each slide six separated microscopic fi elds 
(1728) was calculated. All photomicrographs were taken under the 
light microscope with image analysis software equipment attached 
(Olympus Application Software DP-2BSW) 
Statistical analysis
When evaluating the results of the study, NCSS (Number 
Cruncher Statistical System) 2007&PASS 2008 Statistical Soft-
ware (Utah, USA) was used for the statistical analysis. Kruskal–
Wallis test was used to compare the quantitative data between the 
groups and the Mann Whitney U test was used to determine the 
group that led to the difference. For the comparison of the param-
eter within the group, Wilcoxon sign test was used. The Pearson 
Chi-Square test was used for the comparison of qualitative data. 
The signifi cance level was considered as p < 0.05.
Results 
Intraoperative results
In the relaparotomy of the rats of PIO group, it was observed 
that the small intestine at the proximal of the ligation was largely 
dilated, there was intra-luminal fl uid sequestration and edemous 
wall, and there were no bleeding and necrosis. The ligation did 
not completely close the intestinal lumen and the diameter of the 
colon was normal.
Serological results
A statistically signifi cant difference was found between the 
groups in terms of the levels of serum IgA. The levels of serum IgA 
were signifi cantly higher in the Group IV compared to the Group 
I, Group II and Group III (p < 0.05, p < 0.01). The levels of serum 
IgA were signifi cantly lower in the Group II than in Groups I and 
III (p < 0.01). No statistically signifi cant difference was found be-
tween the levels of serum IgA in the Group I and Group III (p > 
0.05) (Fig. 1). The IgA levels of intestinal fl uid were signifi cantly 
higher in the Group IV than in Group I, II and III (p < 0.01). The 
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Fig. 1. The distribution of the serum IgA levels in each group.
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IgA levels of intestinal fl uid were not statistically different between 
other groups (p > 0.05). In the Group II, III and IV the IgA levels 
obtained from the intestinal fl uid were signifi cantly higher than 
serum IgA levels (p < 0.01, p < 0.05).
Histopathological results
In the Sham group, the histopathological fi ndings obtained 
from small intestine (Fig. 2A) and colon were normal, the intesti-
nal villus lengths and the numbers of small intestinal and colonic 
goblet cells were greater than in other groups (p < 0.01). In the 
Group II, it was observed that the villus length in the small intes-
tine was statistically shorter than in the Groups I, III and IV (p < 
0.01) (Fig. 2B). In addition, it was found that the crypt depths of 
colon were normal. It was seen that the goblet cells in the group 
III (Fig. 2C) were empty and their secretions were released into 
the lumen. The short length of the villi and the reduced number 
of goblet cells were statistically signifi cant only in the rats of the 
Group II (p < 0.01). In the group IV (Fig. 2D), an increased number 
of emptied small intestinal goblet cells and lymphocyte cell infi ltra-
tion in small intestine and colon was observed. In this group, the 
number of intestinal and colonic goblet cells and the villus length 
and crypt depths were statistically signifi cantly higher compared 
to the Groups II and III (p < 0.001).
Microbiological results
In the fi rst group, 3/12 rats (33.3 %) showed growth in MLGs 
and did not show growth in the blood and hepatic cultures. In the 
second group, 100 % of the rats showed growth in MLGs, 5/12 
rats (41.6 %) showed growth in the blood culture and 7/12 (50.8 
%) showed growth in the hepatic cultures. In the third group, 
9/12 rats (75 %) showed growth in MLGs, 4/12 (33.3 %) showed 
growth in blood cultures and 5/12 (41.6 %) showed growth in 
hepatic cultures. In the fourth group, 7/12 rats (50.8 %) showed 
growth in MLGs, 2/12 (16.6 %) showed growth in blood culture 
and 2/12 (16.6 %) showed growth in hepatic culture. In the blood 
cultures, no statistically signifi cant difference was found between 
the groups in terms of growth (p > 0.05). The growth observed 
in MLGs and hepatic cultures of the rats in the Group II was sig-
nifi cantly higher compared to other groups (p < 0.01, p < 0.05) 
(Fig. 3). In all groups, aerobic bacteria were more commonly iso-
lated: E. coli (12, 48 %), Proteus (5, 76 %), Enteroccocus (2, 88 
%). Anaerobic pathogens as Peptostreptococcus (3, 83 %) were 
rarely isolated (Fig. 3). 
Discussion
Pathologic conditions such as necrotizing enterocolitis, sep-
sis, stress, burns, obstructive jaundice, and trauma compromised 
the integrity of the intestinal mucosal barrier (1, 2, 5, 7, 8, 13, 14, 
16). Intestinal mucosa plays an important role in the prevention 
of BT. The partial obstruction impairs intestinal motility, absorp-
tion and secretion and leads to delay in the bacterial elimination, 
which induces intestinal bacterial overgrowth and promotes BT. 
BT is suspected as an important reason in the pathogenesis of the 
sepsis and multi organ failure (3–6). In a study conducted on the 
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Fig. 2. The histopathological fi ndings from small intestine in each 
group. A) The fi gure shows the histopathological fi ndings obtained 
from small intestine in the Group I (hematoxylin-eosin, x100). The 
length of intestinal mucosal villi and the number of goblet cells are 
in normal range (Bar indicates 150 micron). B) The histopathological 
fi ndings obtained from small intestine of the Group II showed short 
length of villus, reduced number of goblet cells and released of goblet 
cells secretions into the lumen (Bar indicates 50 micron) (PAS, x200). 
C) The histopathological fi ndings from small intestine of the Group 
III showed atrophy of the small intestine, deformation of the crypts, 
erosion of the surface epithelial layer, decreased number of goblet 
cells (Bar indicates 50 micron) (PAS, x200). D) The histopathological 
fi ndings of the Group IV (PAS, x100): small intestinal villus lengths 
and the number of goblet cells are close to normal, lumen is reach of 
mucus secretions (Bar indicates 100 micron).
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Fig. 3. The growth in blood culture, MLGs and hepatic tissue culture 
in each group.
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rats, a BT was seen at 60 % in the fi rst 6 hours in the rats under-
went proximal complete ligation of small intestine and at 40 % in 
the MLG in the rats with distal ligation of small intestine. In the 
same study, after 24–48 hours, BT was not only limited to MLGs 
but spread to the liver, spleen, and blood stream. The isolation of 
intestinal bacteria in normally sterile, MLGs is considered as a 
direct evidence of BT. Moreover, after 48 hours, a destruction of 
the villus structures and epithelial cells were observed (4).
In our study, on 5th day after PIO the bacterial growth in 
MLGs, liver and blood cultures in the Group II was 100 %, 50.8 %, 
41.6 % respectively. No signifi cant difference between the groups 
was found in terms of the growth observed in blood cultures. 
Histopathological examination of small intestine in the Group II 
rats demonstrated a destruction/shortening of the villus heights 
and decrease of small intestinal goblet cell numbers. The similar 
results were reported in human studies (6). The large presence of 
bacterial translocation in MLG and other tissues is attributed to 
the fasting and to the long-term partial obstruction. In the fasting 
state, mucosal permeability for macromolecules increases and the 
atrophy of intestinal mucosa, a shortening of villus height and a 
decrease in the growth of epithelial cells and the activity of intes-
tinal enzyme occurred (10). In our Sham group, the BT of 33.3 % 
in MLG might be attributed to the fasting state. It was found that 
trophic factors such as IGF-1, rhGH, glutamine, IgA were effec-
tive in the protection of the intestinal functions and structure as 
well as the prevention of BT (13, 17, 20, 23). GH enhances Th1 
cytokine activity, stimulates immunoglobulin secretion of B cells, 
NK cell activity, phagocytosis, and killing capacity of neutrophils 
and macrophages (18, 20, 21). Prieto et al (23) demonstrated that 
rhGH could promote the release and chemotaxis of neutrophils, 
minimize the spread of bacteria and attenuate bacteria/endotoxin 
translocation, and then reduce plasma endotoxin level. 
Experimental studies showed that, during conditions such as 
intestinal obstruction, obstructive jaundice, burning, trauma, fast-
ing and chemotherapy, serum IgA levels were reduced, the mu-
cosal resistance was decreased and BT occurred (12–17, 20). The 
main immunoglobulin on mucosal surfaces is IgA. IgA2 accounts 
for 15–20 % of the total IgA and it is more abundant in the secre-
tions. IgA neutralizes the bacteria by adhesion. This occurs in the 
mucus. The complex of “mucus-IgA-bacteria” is eliminated with 
peristaltic movements of the bowel. In the rabbits, it was shown 
that intestinal IgA had a protective effect in the neonatal bowel-
derived sepsis (22). Secretory IgA on intestinal mucosal surfaces 
inhibits bacterial adherence to mucosal surfaces and appears to be 
more effective in reducing the spread of bacteria penetrated in-
testinal mucosa than inhibiting the initial translocation of bacteria 
across the intestinal mucosa to the MLGs. A number of studies 
revealed that GH had important role in regulation of humoral and 
cellular immune functions (9, 17, 22–25). The administration of 
rhGH increases the level of total serum and intestinal fl uid IgA and 
thereby, the bacterial growth may be inhibited and bacterial trans-
location may be reduced. In our study, it was demonstrated that 
administration of rhGH increased the total level of IgA in serum 
and in the intestinal fl uid, and that it provided a better prevention 
of bacterial translocation depending on the time. 
Recent studies demonstrated that rhGH might protect the dam-
age of the intestinal mucosa by inhibiting apoptosis of intestinal 
mucosa cells and increasing of IGF-1 levels (11, 15, 17, 25). The 
biological effects of GH are indirectly mediated by IGF-1. IGF-1 
can prevent intestinal atrophy in septic rats and protect the integ-
rity of intestinal structure (11, 12, 13, 18, 21). Gary et al reported 
that the development of bacterial translocation is inversely corre-
lated with serum IGF-1 levels and treatment with IGF-1 decreased 
enterocyte apoptosis (19). Thus, GH improves the impairment of 
the intestinal mucosa and maintains the structure and function of 
the intestinal mucosal barrier (12–14, 20). 
Studies have demonstrated increased villus height and crypt 
depth, when rats were given rhGH alone or in combination with 
glutamine (10, 13, 15, 17, 23). In agreement with these studies, 
we determined a signifi cant increase of the villus height and the 
numbers of small intestinal and colonic goblet cell after 10 days 
of rhGH (1 mg/kg/day) administration, also increased levels of 
serum and intestinal fl uid IgA were observed. However, it was 
observed that an administration of rhGH during 10 days led to a 
decrease by 50 % in the BT seen in MLGs. In the cultures, the 
most abundantly growing bacteria were E. coli. As E. coli is pres-
ent in the bowel, it is thought that it leads to BT more than other 
microorganisms. 
Consequently, the administration of rhGH to the rats for at least 
10 days decreases intestinal damage and subsequent BT, with its 
protective effects in maintaining the integrity of intestinal mucosa 
and the levels of IgA. It was thought that these effects might be 
mediated by IGF-1 and rhGH receptors located in the intestine. 
rhGH could accelerate the clearance of bacteria, minimize the 
spread of bacteria to blood and decrease plasma endotoxin and 
proinfl ammatory cytokines levels. We suggested that it would be 
very useful to perform studies for investigation of rhGH effects 
on BT in humans. 
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